HOUSTON (AP) — The Houston Texans made mistakes in every facet of the game Sunday against the Tennessee Titans to lose for the third time in four games. C.J. Stroud threw two interceptions, the defense gave up multiple big passing plays and Ka′imi Fairbairn missed a 28-yard field goal that would have tied it late in a 32-27 loss . “Just a disappointing loss for us,” coach DeMeco Ryans said. “We didn’t do anything well enough to win this game. Out of all the positives that we did have, there were way too many negatives, too many negative plays.” Jimmie Ward had a 65-yard interception return for a touchdown in the third quarter and the Texans tied a franchise record with eight sacks. Danielle Hunter led the group with a season-high three sacks and Will Anderson Jr. added two in his return after missing two games with an ankle injury. But the offense sputtered for most of the game as Joe Mixon was held to 22 yards on 14 carries. But Ryans refused to blame the offense for the loss. “Our offense did plenty," Ryans said. "They gave us enough points. On defense, we have to be able to stop them.” Chig Okonkwo grabbed a short pass and rumbled 70 yards for a touchdown to put the Titans (3-8) up 30-27 with 91⁄2 minutes remaining. Safety Eric Murray missed a tackle that would have stopped him near midfield. It was the last of three big passing plays the Titans had Sunday. Nick Westbrook-Ikhine got in front of the defense and was wide open for a 38-yard TD catch that made it 10-7 late in the first quarter. Calvin Ridley had a 63-yard reception that set up their next touchdown in the second. “It was just way too many negative plays,” Ryans said. “Defensively, unexplainable explosives for touchdowns. We didn’t play good across the board and that starts with me.” Despite this, the Texans (7-5) had a chance to tie it with less than two minutes remaining, but Fairbairn’s short field-goal attempt sailed wide left. He fell to the ground after the miss before getting up and slamming his helmet on the field. “The most frustrating part about it is out of all the bad things that happened, we still had a chance to finish the game,” Ryans said. “Everything that could go wrong, it went wrong. We still had a chance there to tie it up and finish the game, and we didn’t.” The Texans forced a three-and-out, but couldn’t move the ball after that and Harold Landry sacked Stroud in the end zone for a safety to make it 32-27 and allow Tennessee to snap a two-game skid. Stroud threw for 247 yards and two touchdowns, but his two interceptions Sunday give him five combined in the past three games. He now has more interceptions in 12 games this season (nine) than he had in 15 games as a rookie last season (five). “It’s no secret that I haven’t been playing well ... I’ve got to be harder on myself,” he said. “I’m not going to hold my head down. I know I can be a great player, but I’ve got to make better plays.” AP NFL: https://apnews.com/hub/nfl

Colorado Avalanche (12-9, in the Central Division) vs. Tampa Bay Lightning (10-7-2, in the Atlantic Division) Tampa, Florida; Monday, 7 p.m. EST BOTTOM LINE: The Colorado Avalanche are looking to extend a three-game win streak with a victory against the Tampa Bay Lightning. Tampa Bay has a 10-7-2 record overall and a 6-2-1 record in home games. The Lightning have scored 68 total goals (3.6 per game) to rank 10th in NHL play. Colorado is 12-9 overall and 6-3-0 on the road. The Avalanche have an 8-5-0 record in games they have fewer penalties than their opponent. The teams play Monday for the second time this season. The Lightning won 5-2 in the previous matchup. Anthony Cirelli led the Lightning with two goals. TOP PERFORMERS: Nikita Kucherov has 11 goals and 17 assists for the Lightning. Emil Martinsen Lilleberg has scored goals over the past 10 games. Nathan MacKinnon has scored seven goals with 28 assists for the Avalanche. Sam Malinski has over the last 10 games. LAST 10 GAMES: Lightning: 4-4-2, averaging 3.4 goals, six assists, 3.4 penalties and 9.3 penalty minutes while giving up 2.8 goals per game. Avalanche: 7-3-0, averaging 3.5 goals, 6.2 assists, 2.9 penalties and 5.8 penalty minutes while giving up 2.6 goals per game. INJURIES: Lightning: None listed. Avalanche: None listed. The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .Indo-German Chamber of Commerce hosts 58th annual regional meetPosts Strong Adjusted EBITDA Margin ‎ 1 ‎ for Fiscal Year 2024 and Returns to Positive Sequential Growth in Fiscal Q4 2024 CINCINNATI, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (" Quipt ” or the " Company ”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its fourth quarter and fiscal year 2024 financial results and operational highlights. These results pertain to the three months and year ended September 30, 2024 and are reported in U.S. Dollars. The Company no longer qualifies as a "foreign private issuer” as such term is defined in Rule 405 under the U.S. Securities Act of 1933, as amended, and Rule 3b-4 under the Securities Exchange Act of 1934, as amended (the "Exchange Act”), which means that the Company, as of October 1, 2024, has been required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act applicable to U.S. domestic issuers. Accordingly, the Company is now required to prepare its financial statements filed with the Securities and Exchange Commission (" SEC ”) in accordance with generally accepted accounting principles in the United States (" U.S. GAAP ”), starting with the Company's fourth quarter and full year fiscal 2024 results. In addition, as required pursuant to section 4.3(4) of National Instrument 51-102 - Continuous Disclosure Obligations , the Company must restate and file under the Company's profile on SEDAR+ (www.sedarplus.com), ‎its interim financial reports for the fiscal year ended September 30, 2024 in accordance with U.S. GAAP, such interim financial reports having previously been prepared in accordance with the International Financial Reporting Standards (" IFRS ”). Conference Call Quipt will host its Earnings Conference Call on Tuesday, December 17, 2024 at 10:00 a.m. (ET). Interested parties may participate in the call by dialing: Following the conclusion of the call, a replay of the webcast will be available on the Company's website for at least the first year following the event. Financial Highlights : "Our results for fiscal 2024 reflect the resilience of our business and the scalability of our operating model,” said Gregory Crawford, Chairman and CEO of Quipt. "Despite facing unique challenges this year, we delivered record revenue, positive year-over-year organic growth and maintained a strong Adjusted EBITDA Margin 1 . This performance underscores the strength of our diversified product offering, go-to-market strategy and the adaptability of our team. As we look ahead to calendar 2025 and beyond, we have a high confidence level in our ability to return to consistent, historical organic growth levels. Our focus remains on leveraging the demographic trends such as the aging population and increasing prevalence of chronic respiratory conditions, while expanding our referral base through our growing salesforce and strategic investments. By combining these initiatives with our disciplined approach to inorganic growth, we aim to strengthen our market position and deliver sustained growth. The demand for in-home respiratory solutions continues to grow, and our ability to provide comprehensive, patient-centric care positions us well to capture this opportunity. We remain committed to operational excellence, enhancing our recurring revenue base, and executing on our growth roadmap to drive both scale and profitability. With a strong balance sheet, we are well-equipped to allocate capital toward strategic opportunities, while also investing in organic growth to build long-term shareholder value.” "Our financial performance in fiscal 2024 highlights the stability of our core operations,” added Hardik Mehta, Chief Financial Officer of Quipt. "In the fourth quarter, we returned to positive sequential organic revenue growth, which demonstrates the regained momentum in our business. As we move into calendar 2025, we are seeing strengthening trends across our major product categories, supported by solid referral activity and steady demand for our end-to-end respiratory care solutions. These factors give us confidence that we will return to consistent, historical organic growth levels in calendar 2025. With a scalable operating model, a focused growth strategy, and favorable demographic tailwinds, we are well-positioned to seize the opportunities in front of us.” ABOUT QUIPT HOME MEDICAL CORP. The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company's organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient's services, and making life easier for the patient. Forward-Looking Statements Certain statements contained in this press release constitute "forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 or "forward-looking information" as such term is ‎‎‎‎‎‎defined in applicable Canadian securities legislation (collectively, "forward-looking statements”). The words "may", "would", "could", "should", "potential", ‎‎‎‎‎‎‎"will", "seek", "intend", "plan", "anticipate", "believe", "estimate", "expect", "outlook", or the negatives thereof or variations of such words, and similar expressions ‎‎‎‎‎as ‎they relate to the Company, including: the Company anticipating a return to historical organic growth levels; are intended to ‎identify forward-looking information. All statements ‎other ‎than ‎statements of ‎‎historical fact, including those that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-‎looking statements and may involve estimates, assumptions and uncertainties that could cause actual results or outcomes to differ materially from those expressed in the forward-looking statements. Such statements reflect the ‎Company's ‎current ‎views and ‎‎intentions with respect to future ‎events, and current information available to the ‎Company, and ‎are ‎subject to ‎‎certain risks, uncertainties and ‎assumptions, including, without limitation: the ‎Company successfully identifying, ‎‎‎negotiating and ‎completing additional acquisitions; operating and other financial metrics maintaining their ‎‎current trajectories, the Company not being impacted by any further external and unique events like the Medicare ‎‎75/25 rate cut and the Change Healthcare cybersecurity incident for the remainder of the calendar year and in 2025; and the ‎Company not being subject to a material change to it cost structure. Many ‎factors could cause the actual ‎results, ‎‎performance or achievements that may be ‎expressed ‎or implied by such ‎forward-looking statements to ‎vary from ‎‎those described herein should one or more ‎of these ‎risks or ‎uncertainties materialize. Examples of such ‎risk ‎factors ‎include, without limitation: risks related ‎to credit, market ‎‎‎(including equity, commodity, foreign exchange ‎and interest ‎rate), ‎liquidity, operational ‎‎(including technology ‎and ‎infrastructure), reputational, insurance, ‎strategic, ‎regulatory, legal, ‎environmental, and ‎capital adequacy; the ‎‎general business and economic conditions in ‎the regions ‎in which the ‎Company operates; ‎the ability of the ‎‎Company to execute on key priorities, including the ‎successful ‎completion of ‎acquisitions, ‎business retention, and ‎‎strategic plans and to attract, develop and retain ‎key ‎executives; difficulty ‎integrating ‎newly acquired businesses; ‎‎the ability to implement business strategies and ‎‎pursue business opportunities; low ‎profit ‎market segments; ‎‎disruptions in or attacks (including cyber-attacks) on ‎‎the Company's information ‎technology, ‎internet, network ‎‎access or other voice or data communications systems or ‎‎services; the evolution of ‎various types ‎of fraud or other ‎‎criminal behavior to which the Company is exposed; the ‎‎failure of third parties to ‎comply with ‎their obligations to ‎‎the Company or its affiliates; the impact of new and ‎‎changes to, or application of, ‎current ‎laws and regulations; ‎‎decline of reimbursement rates; dependence on few ‎‎payors; possible new drug ‎discoveries; a ‎novel business ‎model; ‎dependence on key suppliers; granting of permits ‎‎and licenses in a highly ‎regulated ‎business; legal proceedings and litigation, including as it relates to the civil ‎‎investigative demand ("CID”) ‎received from the Department of Justice; ‎increased competition; ‎changes in ‎foreign currency rates; ‎increased ‎‎funding costs and market volatility due to ‎market illiquidity and ‎competition for ‎funding; the ‎availability of funds ‎‎and resources to pursue operations; ‎critical accounting ‎estimates and changes ‎to accounting ‎standards, policies, ‎‎and methods used by the Company; the Company's status as an emerging growth company and a smaller reporting company; the occurrence of ‎natural and unnatural ‎catastrophic ‎events or health epidemics or concerns; as well as those risk factors ‎discussed or ‎‎referred to ‎in the Company's disclosure ‎documents filed with ‎United States Securities and Exchange ‎Commission ‎‎(the "SEC”) and ‎available at www.sec.gov, including the Company's most recent Annual Report on Form 10-K, and with ‎the securities ‎regulatory authorities in certain provinces of ‎Canada and ‎‎‎available at www.sedarplus.com. Should any ‎factor affect ‎the Company in an unexpected manner, or ‎should ‎‎‎assumptions underlying the forward-looking ‎statement prove ‎incorrect, the actual results or events may ‎differ ‎‎‎materially from the results or events predicted. ‎Any such forward-‎looking statements are expressly qualified ‎in their ‎‎‎entirety by this cautionary statement. Moreover, ‎the Company ‎does not assume responsibility for the ‎accuracy or ‎‎‎completeness of such forward-looking ‎statements. The ‎forward-looking statements included in this ‎press release ‎‎‎is made as of the date of this press ‎release and the ‎Company undertakes no obligation to publicly ‎update or revise ‎‎‎any forward-looking statements, ‎other than as ‎required by applicable law‎.‎ Non-GAAP Financial Measures This press release refers to "Organic Growth”, "Recurring Revenue”, "Adjusted EBITDA”, "Adjusted EBITDA Margin” and "Adjusted Net Debt to Adjusted EBITDA Leverage Ratio”, which are non-GAAP financial measures that do not have standardized meanings prescribed by U.S. GAAP. The ‎Company's presentation of these financial measures may not be comparable to similarly titled measures used by ‎other companies. These financial measures are intended to provide additional information to investors concerning ‎the Company's performance.‎ Organic Growth is calculated as the increase in revenues of $34.2 million, less the revenues contributed by acquisitions of $27.1 million, divided by fiscal year 2023 revenue of $211.7 million, or 3%. Recurring Revenue for fiscal 2024 is calculated as rentals of medical equipment of $94.3 million plus sales of respiratory resupplies of $96.5 million for a total of $190.8 million, divided by total revenues of $245.9 million, or 78%. Adjusted EBITDA is calculated as net loss, and adding back depreciation and amortization, right-of-use operating lease amortization and interest, interest expense, net, provision (benefit) for income taxes, professional fees related to civil investigative demand and loss of foreign private issuer status, stock-based compensation, acquisition-related costs, loss on extinguishment of debt, gain (loss) on foreign currency transactions, change in fair value of derivative liability - interest rate swap, and share of loss of equity method investment. The following table shows our non-GAAP measure, Adjusted EBITDA, reconciled to our net income (loss) for the ‎following indicated periods‎ (in $millions)‎:‎ Net Debt to Adjusted EBITDA Leverage Ratio is calculated as Net Debt, divided by (Adjusted EBITDA for Q4 times four), and is reconciled as follows (in $millions): Cole Stevens VP of Corporate Development Quipt Home Medical Corp. 859-300-6455 [email protected] Gregory Crawford Chief Executive Officer Quipt Home Medical Corp. 859-300-6455 [email protected] ___________________________________ 1 Non-GAAP financial measure or ratio. See "Non-GAAP Financial Measures”.‎

TRENTON, N.J. (AP) — A large number of have been reported flying over New Jersey and across the eastern U.S., sparking speculation and concern over where they came from and why. New Jersey Gov. Phil Murphy and U.S. Sen. Andy Kim have both gone out on drone hunts, hoping for answers. The FBI, Homeland Security, state police and other agencies are investigating. Murphy and law enforcement officials have stressed that the drones , but many state and municipal lawmakers have nonetheless called for stricter rules about who can fly the unmanned aircraft — and to be allowed to shoot them out of the sky. Dozens of witnesses statewide since mid-November, including near the Picatinny Arsenal, a military research and manufacturing facility, and over President-elect Donald Trump’s golf course in Bedminster. Murphy, a Democrat, said Monday that equipment supplied by the federal government has yielded little new information. He declined to describe the equipment except to say it was powerful and could even “mitigate” the drones, though he added that’s not currently legal on U.S. soil. The state tallied 12 sightings Saturday and just one on Sunday. Murphy urged Congress to give states more authority to deal with the drones. The among some residents is not lost on the Biden administration, which has faced criticism from Trump for not dealing with the matter more aggressively. White House national security spokesman John Kirby on Monday said the federal government has yet to identify any public safety or national security risks from reported drone sightings in the northeast, saying officials believe they were lawfully flown drones, planes or even stars. “There are more than 1 million drones that are lawfully registered with the Federal Aviation Administration here in the United States,” Kirby said. “And there are thousands of commercial, hobbyist and law enforcement drones that are lawfully in the sky on any given day. That is the ecosystem that we are dealing with.” The federal government has deployed personnel and advanced technology to investigate the reports in New Jersey and other states, and is evaluating each tip reported by citizens, he said. The FBI received more than 5000 tips in recent weeks, he added, with only “about 100” deemed credible enough to require additional investigation. Authorities say they do not know. The Department of Homeland Security and FBI said they have no evidence that the aircraft pose “a national security or public safety threat or have a foreign nexus.” Speculation has nevertheless raged online, with some expressing concerns that the drones could be part of a nefarious plot by foreign agents. Officials stress that ongoing investigations have found no evidence to support such concerns, but U.S. Rep Chris Smith, a Republican, on Saturday echoed such speculation. “The elusive maneuvering of these drones suggests a major military power sophistication that begs the question whether they have been deployed to test our defense capabilities — or worse — by violent dictatorships, perhaps maybe Russia, or China, or Iran, or North Korea,” he said. On Monday, Pentagon spokesperson Maj. Gen. Pat Ryder cast doubt on the idea that the drones are engaged in intelligence gathering, given how loud and bright they are. He said about 1 million drones are registered drones in the U.S. and about 8,000 flying on any given day. Pentagon spokeswoman Sabrina Singh has said the aircraft are not U.S. military drones. In Boston, city police arrested two men accused of operating a drone “dangerously close” to Logan Airport on Saturday night. Authorities said an officer using drone monitoring technology detected the aircraft and the location of the operators. A third man fled police and remains at large. Authorities said the two men face trespassing charges and could face more charges and fines. Drones flying around near Dayton, Ohio, forced base officials to close its airspace for about four hours late Friday into early Saturday, said Robert Purtiman, a base spokesperson. It was the first time drones had been spotted at the base, one of the largest in the world, and no sightings have been reported since, Purtiman said Monday. He said the drones had no impact on any facilities on the base. Trump has said he believes the government knows more than it’s saying. “Let the public know, and now. Otherwise, shoot them down!!!” he posted on Truth Social. Kim said he’s heard no support for the notion the government is hiding anything. He said a lack of faith in institutions is playing a key part in the saga. “Nothing that I’m seeing, nothing that I’ve engaged in gives me any impression of that nature. But like, I get it, some people won’t believe me, right? Because that’s the level of distrust that we face," Kim said Monday. Sen. Richard Blumenthal of Connecticut last week called for the drones to be “shot down." Rep. Smith urged the Pentagon to authorize the use of force to bring down one or more drones to try to figure out who deployed them. The objects could be downed over the ocean or in an unpopulated area on land, Smith said Saturday. “Why can't we bag at least one of these drones and get to the bottom of it?” Smith said. Monmouth County Sheriff Shaun Golden said members of the public must not try to shoot down drones, as that would violate state and federal laws. Drone sightings were also reported in New York, where a permit is required. Mayor Eric Adams said the city was investigating and collaborating with New Jersey and federal officials. The runways at Stewart International Airport — about 60 miles (100 kilometers) north of the city — were shut down for about an hour Friday night because of drone activity, Gov. Kathy Hochul said. “This has gone too far,” she said in a statement. The governor called on Congress to strengthen the FAA’s oversight of drones and give more investigative authority to state and local law enforcement. Associated Press writers John Seewer in Toledo, Ohio; Bruce Schreiner in Shelbyville, Kentucky; and Aamer Madhani in West Palm Beach, Florida, contributed.Trinasolar Establishes A Partnership With Centro Universitário FACENS To Empower Brazilian Market On Its Advanced Smart Solar Solutions